CORGENIX MEDICAL CORP/CO: 10-Q filed 2012-05-14

Name: CORGENIX MEDICAL CORP/CO: 10-Q filed 2012-05-14
Creator: CORGENIX MEDICAL CORP/CO

What CORGENIX MEDICAL CORP/CO reported in its quarterly report filed 2012-05-14 (fiscal Q3 2012): 37 published measures, 103 facts as tagged in accession 0001104659-12-036667.

This filing

Form: 10-Q (quarterly report)
Filed: 2012-05-14
Fiscal period: fiscal Q3 2012
Accession: 0001104659-12-036667 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CORGENIX MEDICAL CORP/CO filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2012-03-31	6,492,881	USD
At 2011-06-30	6,953,070	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2012-03-31	1,700,113	USD
At 2011-06-30	2,748,670	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2012-03-31	4,781,030	USD
At 2011-06-30	4,193,908	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2012-03-31	1,013,422	USD
At 2011-06-30	1,095,239	USD
At 2011-03-31	1,086,263	USD
At 2010-06-30	494,096	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	-185,145	USD	91
2011-07-01 to 2012-03-31	-320,736	USD	275
2011-01-01 to 2011-03-31	-164,809	USD	90
2010-07-01 to 2011-03-31	-574,994	USD	274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2012-03-31	-16,316,965	USD
At 2011-06-30	-15,981,150	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	45,996,598	shares	91
2011-07-01 to 2012-03-31	44,180,380	shares	275
2011-01-01 to 2011-03-31	40,900,832	shares	90
2010-07-01 to 2011-03-31	39,906,418	shares	274

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	45,996,598	shares	91
2011-07-01 to 2012-03-31	44,180,380	shares	275
2011-01-01 to 2011-03-31	40,900,832	shares	90
2010-07-01 to 2011-03-31	39,906,418	shares	274

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	0	USD/shares	91
2011-07-01 to 2012-03-31	0	USD/shares	275
2011-01-01 to 2011-03-31	0	USD/shares	90
2010-07-01 to 2011-03-31	-0.01	USD/shares	274

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	0	USD/shares	91
2011-07-01 to 2012-03-31	0	USD/shares	275
2011-01-01 to 2011-03-31	0	USD/shares	90
2010-07-01 to 2011-03-31	-0.01	USD/shares	274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2012-03-31	1,086,635	USD
At 2011-06-30	1,076,173	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2011-07-01 to 2012-03-31	24,889	USD	275
2010-07-01 to 2011-03-31	489	USD	274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	-169,944	USD	91
2011-07-01 to 2012-03-31	-220,973	USD	275
2011-01-01 to 2011-03-31	-110,719	USD	90
2010-07-01 to 2011-03-31	-366,591	USD	274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2012-03-31	5,025,296	USD
At 2011-06-30	5,465,682	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	15,337	USD	91
2011-07-01 to 2012-03-31	104,444	USD	275
2011-01-01 to 2011-03-31	54,292	USD	90
2010-07-01 to 2011-03-31	209,067	USD	274

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2012-03-31	1,198,862	USD
At 2011-06-30	2,148,553	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2012-03-31	627,828	USD
At 2011-06-30	602,964	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2012-03-31	1,562,884	USD
At 2011-06-30	1,427,032	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	1,182,525	USD	91
2011-07-01 to 2012-03-31	3,218,286	USD	275
2011-01-01 to 2011-03-31	997,563	USD	90
2010-07-01 to 2011-03-31	3,188,727	USD	274

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2012-03-31	2,404,024	USD
At 2011-06-30	2,800,473	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	1,012,581	USD	91
2011-07-01 to 2012-03-31	2,997,313	USD	275
2011-01-01 to 2011-03-31	886,844	USD	90
2010-07-01 to 2011-03-31	2,822,136	USD	274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	166,745	USD	91
2011-07-01 to 2012-03-31	332,003	USD	275
2011-01-01 to 2011-03-31	49,331	USD	90
2010-07-01 to 2011-03-31	219,280	USD	274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2012-03-31	46,419,466	shares
At 2011-06-30	40,894,847	shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2011-06-30	-49,296	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2012-03-31	3,600,179	USD
At 2011-06-30	3,480,945	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2012-03-31	2,513,544	USD
At 2011-06-30	2,404,772	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2012-03-31	85,160	USD
At 2011-06-30	93,782	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2012-03-31	144,163	USD
At 2011-06-30	143,437	USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	-185,145	USD	91
2011-07-01 to 2012-03-31	-320,736	USD	275
2011-01-01 to 2011-03-31	-166,368	USD	90
2010-07-01 to 2011-03-31	-566,403	USD	274

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	-190,067	USD	91
2011-07-01 to 2012-03-31	-335,815	USD	275
2011-01-01 to 2011-03-31	-169,887	USD	90
2010-07-01 to 2011-03-31	-591,404	USD	274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	505,253	USD	91
2011-07-01 to 2012-03-31	1,400,828	USD	275
2011-01-01 to 2011-03-31	492,052	USD	90
2010-07-01 to 2011-03-31	1,435,924	USD	274

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2011-07-01 to 2012-03-31	218,451	USD	275
2010-07-01 to 2011-03-31	323,243	USD	274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2012-01-01 to 2012-03-31	-15,201	USD	91
2011-07-01 to 2012-03-31	-99,763	USD	275
2011-01-01 to 2011-03-31	-54,090	USD	90
2010-07-01 to 2011-03-31	-208,403	USD	274

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2011-07-01 to 2012-03-31	107,375	USD	275
2010-07-01 to 2011-03-31	177,697	USD	274

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2011-07-01 to 2012-03-31	810,637	USD	275
2010-07-01 to 2011-03-31	1,404,519	USD	274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2011-07-01 to 2012-03-31	-396,449	USD	275
2010-07-01 to 2011-03-31	336,056	USD	274

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2011-07-01 to 2012-03-31	24,864	USD	275
2010-07-01 to 2011-03-31	231,460	USD	274

Inspect the source

Entity: CORGENIX MEDICAL CORP/CO / CIK 0001063665
Captured: 2026-09-22 19:38 UTC
SEC response SHA-256: d5c9a731c224e5e3bc1810cb7082f73228091cd19a1b3e75105550e152ab2c14

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001063665.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))